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Abstract  
Before the era of complete resistance to antibiotics due to their extensive use in poultry farms, 
new strategies were discovered, one of them was the use of nanoparticles to enhance the action 
of antibiotics. Therefore, this study was carried out to find out the antibacterial effect of silver 
nanoparticles (AgNPs) either separately or in combination with antibiotics. The obtained data 
showed the antibacterial activity of AgNPs against the tested Escherichia coli and Salmonella 
strains with MIC level of 0.85 µg/mL. Synergistic effects of AgNPs with antibiotics against E. 
coli revealed two-fold drop in MIC of ciprofloxacin and amoxicillin. Meanwhile, there was 
three-fold drop in MIC of gentamicin, cefotaxime and neomycin. Significant ﬁnding was 
observed in the case of the synergism of AgNPs with amoxicillin and gentamicin, the examined 
E. coli O2 resistant to amoxicillin and gentamicin became sensitive when the antibiotics were 
combined with AgNPs. It could be concluded that AgNPs can be easily produced by Rosemary 
aqueous extracts as low-cost, eco-friendly method for generating AgNPs. New generations of 
bactericidal compounds containing AgNPs could be successfully used in poultry farms for 
prevention and treating E. coli infections. 
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Introduction 
Bacterial infections in commercial poultry 
farms cause significant losses in poultry 
industry. There are different classes of 
bacteria, which are distributed in commercial 
broiler chicken farms. Among these, 
Escherichia coli and Salmonella species are 
associated with diverse manifestations in 
broiler chickens and are considered important 
foodborne pathogens to human beings [1]. 
Antimicrobial resistance is one of the most 
common serious threats facing poultry 
industry. The control of antibiotics resistance 
appears to be decisive to maintain high income 
and condense losses [2]. This problem of 
antimicrobial resistance pushed the scientists 
to search for new alternatives to antibiotics. 
Nanotechnology is rising as a rapidly 
mounting branch with its application in 
manufacturing and science [3]. Nanoparticles 
are groups of particles with size ranged from 
1–100 nm where the nano is one billionth of 
meter (109). This size of nanoparticles results 
in different characters than those of the 
materials of large particles. The unique 
properties of nano material may due to their 
smaller size and quantum dot. The 
nanoparticles of metals such as silver, copper, 
zinc, and gold have a bactericidal feature [4,5]. 
Silver nanoparticles (AgNPs) have been 
confirmed to be an effective antimicrobial 
agent against bacteria, viruses and other 
micro-organisms [6,7].  
AgNPs could be obtained by different 
techniques such as physical, chemical or 
biological methods. Biological conversion 
methods could be done using microorganism, 
enzymes and plant extract, and at the same 
time is safe and eco-friendly as it does not use 
harmful chemicals for the conversion of silver 
nitrate particles to nanoparticles in comparison 
to other methods [8,9].   
Feng et al. [10], Percival et al. [11] and 
Sondi and Salopek-Sondi [12] investigated the 
antibacterial effect of silver nanoparticles 
against different classes of microorganisms 
such as E. coli and Staph. aureus. The 
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mechanism of the antibacterial action of 
AgNPs is due to the attachment of the particles 
to the surface of the cell membrane, resulting 
in disruption of membrane permeability and 
the cell respiratory functions [13].  
In broiler production, there is a great need 
to minimize the degree of bacterial resistance 
against many used antibiotics. Using AgNPs 
alone may act as a substitute to antibiotics, 
while, their use in combination with antibiotics 
results in synergy of their power against 
bacteria. The present study, therefore, aimed to 
estimate the effect of AgNPs application either 
alone or in combination with commonly used 
antibiotics on the reduction of MIC levels of 
these antimicrobial agents and converting the 
tested Salmonella and E. coli strains from the 
resistance status to sensitive one. 
Material and Methods 
Samples 
Sampling was carried out from July-2016 to 
November -2016 in ten broiler chicken farms 
located in Assiut City, Egypt, with birds aging 
27 to 35 days. For Salmonella isolation, 10 
individual cloacal swabs were randomly 
collected from each farm from birds with 
respiratory, intestinal and/or locomotor signs. 
The samples were then transported in 1.5 mL 
tubes containing 750 µL of Brain Heart 
Infusion (BHI) broth refrigerated in ice box to 
the Laboratory of Poultry Diseases 
department, Faculty of Veterinary Medicine, 
Assiut University, Assiut, Egypt. For E. coli 
isolation, 10 liver samples were collected 
separately from freshly dead birds at each farm 
then transported refrigerated in ice box to the 
laboratory for finalizing the steps of isolation. 
Isolation and Identification of the suspected 
bacteria 
For the isolation of Salmonella spp., the 
following method was used in brief: BHI broth 
tubes were incubated at 37ºC for 18 hours then 
a loopful was transferred to Rappaport-
Vassiliadis broth then incubated at 37ºC for 24 
hours. Samples were streaked on Brilliant 
Green agar with Novobiocin (40 µg/mL) and 
Salmonella-Shigella agar and incubated for 24 
hours at 37ºC. After incubation, colonies from 
each sample with characteristic morphology 
were subjected to biochemical identification 
[14]. Isolates with biochemical profile 
compatible with Salmonella spp. were 
identified serologically using antisera (Difco) 
in agglutination tests on the basis of somatic O 
antigen and phase 1 and phase 2 flagella 
antigens according to the Kauffmann-White 
scheme. 
For isolation of E. coli, the surfaces of 
collected livers were seared with hot spatula 
then a loopful was taken from each liver 
sample and placed in BHI at 37ºC for 18 
hours. A loopful of the incubated BHI broth 
was then streaked on Eosin Methylene Blue 
(EMB) agar and incubated at 37°C for 24 h. 
Colonies with characteristics morphology 
(dark colored colonies with a brilliant green 
sheen were selected and identified with 
biochemical reaction [14]. After that, the 
suspected strains were divided into two parts. 
The first part was used for serological 
identification and the second part for carrying 
out the antimicrobial resistance for the selected 
antibiotics and the effect of nanoparticles in 
reducing the resistance of bacteria to the 
examined antimicrobial agents. 
Biosynthesis of silver nanoparticles 
Aqueous extracts (10%) of Rosmarinus 
officinalis (rosemary) were made for the 
preparation of the silver nanoparticles as the 
following: ten grams of dry ground rosemary 
powder were dissolved in 100 mL distilled 
water then heated at 80°C for one hour. After 
cooling b y1 hr, the extract was filtered with 
Whatman filter paper no 1.  
The silver nitrate (AgNO3) (AR grade ≥ 
99.9% purity, Sigma-Aldrich) was used as a 
source for silver nanoparticles by adding 169.3 
mg of silver nitrate (0.01M) to the 100 mL of 
rosemary aqueous extract in a dark container 
to diminish photo-activation of silver nitrate 
for 24 hours at room temperature. The 
synthesis of silver nanoparticles was indicated 
by the color change in the solution, from 
colorless to yellowish brown [15]. 
The UV absorption of the prepared sample 
was recorded by using UV-Vis which is 
spectroscopy double beam PC Scanning 
Spectrophotometer UV Evolution 300 from 
lambomed. A computer data system is UV 
Win5 software v 5.0.5 used for measuring 
wavelength and absorbance.  
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Spectrophotometer ranges from 200 to 900 
nm using 1 cm matched Stoppard quartz.  
Atomic absorption spectroscopy  
The concentration of the silver 
nanoparticles was measured based on atomic 
absorption technique by using absorption 
technique spectrophotometer (Buck model 210 
VGP, Buck Scientific Inc. East Norwalk, CT, 
USA). 
The conversion of Ag to nanoparticles was 
carried out following the method described by 
Sharma et al. [16]. Briefly, by centrifugation 
of one mL of the sample at 14.000 rpm, the 
unreacted silver nitrate (Ag+ ions) were in the 
supernatant because Ag ions are much smaller 
than Ag nanoparticles (Ag0) and the formed 
pellets contained the Ag nanoparticles (Ag0). 
The obtained supernatant solution was then 
analyzed by AAS to detect the amount of Ag+ 
ions. The decrease in the concentration of the 
Ag+ ions notifies the conversion of Ag+ to Ag0. 
Transmission Electron Microscope (TEM) 
The morphology and sizes of silver 
nanoparticles were determined in the 3rd 
concentration by TEM micrographs using the 
JEOLTEM100CXII (Electron Microscope 
Unit, Assiut University, Egypt).  The sample 
was prepared by placing a drop of synthesized 
silver nanoparticles on a negative carbon 
coated copper grids and dried in air [17]. 
Detection of minimum inhibitory 
concentration (MIC) 
The antimicrobial effect of AgNps, 
amoxicillin, cefotaxime, ciprofloxain and 
gentamicin was checked in microtiter plate 
96 wells using double fold micro-dilution 
method against E. coli O1, O2, O78 and S. 
Typhimurium and S. Enteritidis in a density of 
105 CFU equal to 0.1 absorbance on OD 625 
[18]. The concentration of each antibiotic 
started from 512mg/L and biosynthesized 
silver nanoparticles begin with 13.6 µg/mL 
(13.6 mg/L) using two-fold serial dilution in 
Mueller–Hinton (MH) broth (100 µL in each 
well). 
To each concentration, 100 µL of 105 
CFU/mL of the tested microorganisms (E. 
coli O1, O2 and O78, Typhimurium and S. 
Enteritidis) were added in a final volume of 
100 µL. The bacterial inoculum broth was 
taken as a positive control and another 
containing either Ag nanoparticles or 
antimicrobials broth without bacterial 
inoculums was considered as a negative 
control. The microtiter plates were incubated 
at 37ºC for 24 hours and examined for the 
lowest concentration showing no detectable 
growth (MIC). The breakpoints of sensitivity 
and resistance   for Enterobacteriacea 
(including Salmonella and Shigella spp. are as 
follows: amoxicillin (S: < 8 and R: > 8), 
neomycin (S: < 32 and R: > 32), gentamicin 
(S: < 4 and R: > 16), ciprofloxacin (S: < 1 and 
R: > 4) and cefotaxime (S: < 1 and R: > 4) 
[18]. 
Combination effect of silver nanoparticles 
with the used antibiotics 
Silver nanoparticles were mixed with each 
antibiotic solution (50 µL, each) and different 
concentrations were prepared with the 
microorganisms (100 µL of 5×105 CFU/mL) 
in a final volume of 200 µL as above using the 
double fold serial dilution in the 96-well 
microtiter plates. The plates were incubated 
and tested for MIC. 
To evaluate the effect of the combinations, 
the fractional inhibitory concentration (FIC) 
was calculated with the following equation: 
FIC of antibiotic or silver nanoparticles =MIC 
in combination divided on MIC of the 
antibiotic or the silver nanoparticles alone 
[19]. The FIC index (FICI), calculated as the 
sum of each FIC, was interpreted as follows: 
FICI<0.5, synergy; 0.5≤FICI<1, partial 
synergy; FICI=1, additive; 2≥FICI<4, 
indifferent; 4<FICI, antagonism [20,21]. 
Results 
Isolation and serotyping 
Out of 100 examined samples, E. coli were 
recovered from 45%. In contrast, Salmonella 
isolates were isolated from 5% of individual 
cloacal swab samples. According to 
serotyping, the majority of the isolated E. coli 
belonged to O78 (23 out of 45 positive 
strains), followed by O2 (12 out of 45 E. coli 
strains) and O1 was recovered from 10 out of 
the 45 strains. However, 3 out of 5 positive 
Salmonella isolates were S. Typhimurium, 
while, the remaining 2 were S. Enteritidis. 
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Figure 1: UV-VIS absorption spectrum of the obtained silver Nanoparticles. 
 
Characterization of nanoparticles 
Absorption spectra of silver nitrate 
nanoparticles formed in the reaction media has 
absorbance peak at 420 nm (Figure 1). Atomic 
absorption spectroscopy was determined by 
the concentration of the AgNPs at 13.6 ug/mL 
through a decrease in concentration of Ag ions 
from 1690 µg/mL to 1676.4 µg/mL indicating 
the conversion of unreacted silver (Ag+) to the 
converted silver nanoparticles (Ag0). 
ATEM image of the prepared silver 
nanoparticles is shown in Figure 2. The Ag 
nanoparticles are spherical in shape with 
smooth surface morphology. The diameter of 
the nanoparticles ranged from 7.55 nm to 16.5 
nm. TEM image also shows that the produced 
nanoparticles are more or less uniform in size 
and shape.  
 
 
 
Figure 2: Transmission Electron microscope (TEM) image showing Ag-Nps formed by rosemary  
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Minimum inhibitory concentration (MIC) 
determination 
For all the tested strains of E. coli and 
Salmonella species, the MIC of the prepared 
silver nanoparticles alone were 0.85 µg/mL.  
The antibacterial activity of the used 
antibiotics 
Ciprofloxacin  
Table 1 shows the antibacterial activity of 
ciprofloxacin alone /or in combination with 
silver nanoparticles. The observed MIC of 
ciprofloxacin with the examined strains for E. 
coli and Salmonella strains showed resistant 
breakpoints levels either alone or even in 
addition of silver nanoparticles but have a 
minimizing effect on the breakpoints, but 
could not reach to the sensitive breakpoint 
levels.  
However, the FIC index showed synergy in 
case of E. coli O2, partial synergy in case of E. 
coli O1, indifference in case of E. coli O78 
and S. Enteritidis, but it was additive in case of 
S. Typhimurium.  
Amoxicillin  
As shown in Table (1), two strains of E. 
coli O1 and O2 were converted from resistant 
strains with breakpoint 16 mg/L to susceptible 
isolates with breakpoint 8 and 4 mg/L, 
respectively, after the addition of silver 
nanoparticles. In case of Salmonella strains; S. 
Enteritidis became more sensitive to 
amoxicillin with breakpoint 8 mg/L before 
addition of silver nanoparticles and reached to 
4 mg/L after addition of silver nanoparticles. 
In contrary, S. Typhimurium strains were 
converted from sensitive to resistant with 
breakpoint of 32 mg/L. However, the FICI 
showed synergy in case of E. coli O2 and S. 
Enteritidis, additive effect in case of E. coli 
O78 and antagonism with S. Typhimurium. 
 
Table 1: Antibacterial activity of ciprofloxacin and amoxicillin alone and in combination with silver 
nanoparticles. 
Ciprofloxacin 
Microorganisms 
MIC 
FICI Effect 
Ciprofloxacin alone Combination 
(mg/mL) (μg/mL) (mg/mL)   
Escherichia coli O1 16 0.2125 8 0.75 Partial synergy 
Escherichia coli O2 64 0. 2125 8 0.375 Synergy (S) 
Escherichia coli O78 128 0.85 32 1.25 Indifferent 
Salmonella Typhimurium 32 0.425 16 1 Additive (A) 
Salmonella Enteritidis 64 0.85 32 1.5 Indifferent 
 
Amoxicillin 
Microorganisms 
MIC 
FICI Effect 
Amoxicillin alone Combination 
 (mg/mL) (μg/mL) (mg/mL)   
Escherichia coli O1 16 0.2125 8 0.75 Partial synergy 
Escherichia coli O2 16 0. 1062 4 0.375 Synergy (S) 
Escherichia coli O78 32 0.425 16 1 Additive (A) 
Salmonella Typhimurium 8 1.7 32 6 Antagonism 
Salmonella Enteritidis 8 0. 1062 4 0.375 Synergy (S) 
S: Synergistic. A: Additive. I: Indifferent.  
 
Gentamycin  
According to that shown in Table 2, all the 
examined strains of E. coli were resistant to 
gentamicin where the breakpoints ranged from 
32-64 mg/L. After addition of the silver 
nanoparticles, the MIC breakpoints of 
gentamicin were lowered to 8 and 4 mg/L for 
O1 and O2 strains, respectively, but O78 was 
not affected. In case of S. Typhimurium and S. 
Enteritidis and after the addition of silver 
nanoparticles, the levels of MIC breakpoints 
became higher than that observed with the 
antibiotic alone. FIC index showed synergy in 
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case of E. coli O1 and O2, indifference in case 
of E. coli O78 and S. Typhimurium, but it 
showed antagonism in case of S. Enteritidis. 
Cefotaxime 
The recorded MIC levels of cefotaxime 
alone showed resistance and ranged from 32 to 
512 mg/L for E. coli and 2 to 128 mg/L for 
Salmonella strains as shown in Table 2. In 
case of addition of silver nanoparticles to the 
cefotaxime, the MIC levels were lowered but 
the examined isolates were still resistant and 
the MIC ranged from 4- 128 mg/L for E. coli 
and Salmonella strains.  The FIC index 
showed synergy in case of E. coli O2, 
indifference in case of S. Enteritidis, additive 
in case of E. coli O1, but it showed 
antagonism in case of E. coli O78 and S. 
Typhimurium. 
Neomycin 
The observed MIC breakpoints of 
neomycin alone showed sensitivity (32 mg/ml) 
against E. coli O2 and O78, and resistant 
breakpoint 64 mg/mL for O1 (Table 3). 
However, Salmonella species recorded the 
sensitive level 16 mg/mL for S. Typhimurium 
and resistant breakpoint 64 mg/mL for S. 
Enteritidis. In case of AgNPs addition to the 
antibiotics, the FICI showed synergistic effect 
with neomycin against O1, O2 and S. 
Enteritidis, but it showed antagonism in case 
of E. coli O78 and S. Typhimurium. 
 
Table 2: Antibacterial activity of gentamicin and cefotaxime alone and in combination with silver 
nanoparticles 
Gentamicin 
Microorganisms 
MIC 
FICI Effect 
Gentamicin alone Combination 
 (mg/mL) (μg/mL) (mg/mL)   
Escherichia coli O1 64 0.2125 8 0.375 Synergy (S) 
Escherichia coli O2 32 0. 1062 4 0.315 Synergy (S) 
Escherichia coli O78 64 1.7 64 3 Indifferent 
Salmonella Typhimurium 2 0. 1062 4 2.12 Indifferent 
Salmonella Enteritidis 8 0. 85 32 5 Antagonism 
 
Cefotaxime 
Microorganisms 
MIC 
FICI Effect 
Cefotaxime alone Combination 
 (mg/mL) (μg/mL) (mg/mL)   
Escherichia coli O1 512 0.85 32 1.0625 Additive 
Escherichia coli O2 32 0. 1062 4 0.25 Synergy (S) 
Escherichia coli O78 256 3.4 128 4.5 Antagonism 
Salmonella Typhimurium 128 3.4 128 5 Antagonism 
Salmonella Enteritidis 2 0. 1062 4 2.125 Indifferent 
S: Synergistic. A: Additive. I: Indifferent. 
 
Discussion 
Avian collibacillosis and salmonellosis are 
considered to be the major bacterial diseases in 
poultry industry worldwide. In addition, 
collibacillosis and salmonellosis are the most 
common avian diseases that are communicable 
to humans [22]. In the last decade, it is well 
known that bacterial antimicrobial resistance is 
an increasing threat against elimination of 
bacterial infections particularly in broiler 
farms.  
A substitute to overcome the drug 
resistance of microorganisms is immediately 
needed. Silver (Ag) has been used as 
antimicrobial agent against microorganisms 
[23]. However, there are some restrictions in 
using Ag salts as antimicrobial agents, 
therefore, using silver in nano form could be a 
solution.  
For the assessment of the antimicrobial 
effects of AgNPs, E. coli and Salmonella 
strains were used in this study. The effect was 
investigated by MIC microdilution method. 
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Our results revealed that the bacterial growth 
was completely inhibited in the presence of 
AgNPs on the 0.85 µg/mL. It appears that 
these particles are bactericidal at low 
concentration. In accordance with our results, 
Russel and Hugo [24] and Narayanan et al.  
[25] reported the biocidal effect of silver-based 
compounds against wide range of bacteria 
such as E. coli, Staphylococcus aureus, 
Staphylococcus epidermidis and Streptococcus 
pyogenes, Salmonella Typhi and Klebsiella 
pneumonia. 
 
Table 3: Antibacterial activity of neomycin alone and in combination with silver nanoparticles.  
 
Microorganisms 
MIC 
FICI Effect 
Neomycin alone Combination 
 (mg/mL) (μg/mL) (mg/mL)   
Escherichia coli O1 64 0.2125 8 0.375 Synergy (S) 
Escherichia coli O2 32 0.2125 8 0.5 Synergy (S) 
Escherichia coli O78 32 1.7 64 4 Antagonism 
Salmonella Typhimurium 16 1.7 64 6 Antagonism 
Salmonella Enteritidis 64 0.85 32 1.5 Indifferent 
S: Synergistic. A: Additive. I: Indifferent. 
 
This action of bactericidal capability of 
AgNPs was attributed to several mechanisms; 
firstly, their small size and large dispersion 
surface to volume ratio which allows them to 
interact closely with microbial membranes 
[26,27]. Thus, helping the Silver nanoparticles 
(AgNPs) to combine with the bacterial cell 
wall and membrane and leads to stopping the 
respiration progression [28]. These effects lead 
to breakdown of the plasma membrane causing 
exhaustion of intracellular ATP [29]. 
Secondly, the metal oxides carry the positive 
charge while the microorganism carry negative 
charge, that causes electromagnetic attraction 
between microorganism and the metal oxides 
and leads to oxidization and finally death of 
microorganism [30,31]. Finally, nano-Ags 
generate hydroxyl radicals, a highly reactive 
oxygen species induced by bactericidal agents 
[32]. 
Our findings showed the bactericidal effects 
of silver nanoparticles that synthesized by 
Rosemary on E. coli and Salmonella strains as 
well as a synergistic effect with gentamycin. 
This result was in agreement with Lee et al. 
[33]; Markowska et al. [34]; Singh et al. [35] 
who reported preliminary results concerning 
the synergistic effect of amoxicillin and 
AgNPs against E. coli and no synergetic effect 
was emphasized in combinations of AgNPs 
with oxacillin, ciproﬂoxacin, meropenem, and 
ceftazidime. 
In a previous study on the synergistic effect 
of nanoparticles with gentamicin and 
neomycin on S. aureus causing mastitis, 
Jamaran and Zarif [36] reported the synergistic 
effects of gentamicin with AgNPs on 50% of 
the examined strains and on 45% of the strains 
when the neomycin was used with AgNPs. In 
the same respect, Birla et al. [37] observed the 
synergistic action between silver nanoparticles 
(AgNPs) and ampicillin, gentamicin, 
kanamycin, streptomycin and vancomycin 
against E. coli. 
The current study also clearly demonstrated 
that antibiotic-resistant bacteria become 
susceptible when an antibiotic was combined 
with AgNPs as proved in case of the 
synergistic effect of ampicillin with AgNPs 
against E. coli. This phenomenon was reported 
previously by Singh and Brown [35,38]. In 
addition, Brown et al. [38] reported that 
AgNPs with ampicillin were effective against 
ampicillin-resistant E. coli. 
Conclusion 
A strong synergistic effect of broad-
spectrum antibiotics with well characterized 
AgNPs silver nanoparticles of an average size 
of 8.5 nm to 16.5 nm synthesized using 
rosemary extract was observed. This green 
synthesis method is eco-friendly than chemical 
method. It is also inexpensive and pollutant 
free. Our findings support the argue that nano-
Ags have substantial effective antibacterial 
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activity and merit further investigation for 
field trials in poultry farms. 
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 الملخص العربي
 باستخدام الدجاج من المعزولة والايشريشياكولاي السالمونيلا لميكروبي الحيوية للمضادات الحساسية تحسين
 في محافظة أسيوطللفضة  والنان جزيئات
 3، وليد أحمد السيد2، فاطمة مختار محمد1مؤمن عبدالعظيم محمد
 أسيوط-الدواجن، كلية الطب البيطرى، جامعة أسيوطقسم أمراض 1
 أسيوط -قسم أمراض الدواجن، معهد بحوث صحة الحيوان، المعمل الأقليمى أسيوط2
 أسيوط-قسم الكيمياء،كلية العلوم، جامعة أسيوط3
 
وذللك للاستخدام الشائع للمضادات الحيوية، تم اكتشاف استراتيجيات  قبل أن ندخل عصر المقاومة الكاملة للمضادات الحيوية
الدراسة لتعزيز عمل المضادات الحيوية. لذلك، تم تنفيذ هذه  أو متناهية الصغر  استخدام الجسيمات النانويةجديدة، واحدة منها 
إما بشكل منفصل أو بالاتحاد مع المضادات الحيوية  البكترياعلى ا متناهية الصغر لفضةاجسيمات لمعرفة التأثير المضاد ل
ضد عترات  متناهية الصغر لفضةالجسيمات نشاط المضاد للبكتيريا للا النتائج التي تم الحصول عليه المستخدمة. وأظهرت
ميكروجرام / مل. كما أظهرت نتائجنا تأثيرات متآزرة مختلفة للمضادات الحيوية  58.0عند مستوى لسالمونيلاالايكولاي وا
 لفضةاجسيمات وية المستخدمة مع المستعملة على عترات الايكولاي المستهدفة حيث كان التأثير المثبط الأدنى للمضادات الحي
في الغالب مرتين أقل من تلك المضادات الحيوية المستخدمة بمفردها (سيبروفلوكساسين وأموكسيسيلين) وأكثر  متناهية الصغر
في حالة تأثير التآزر أموكسيسيلين و  هولوحظ نتيجة مدهش من ثلاثة أضعاف مع جنتاميسين، سيفوتاكسيم والنيومايسين.
مقاومة  -2O حيث أظهر استخدام هذه المضادات الحيوية وحدها ضد الايكولاي متناهية الصغر لفضةاجسيمات جنتاميسين مع 
 إلى أموكسيكسيلين و جنتاميسين تم استعادة النشاط متناهية الصغر لفضةاجسيمات إضافة  عند  لهذه المضادات الحيوية، ولكن
مع المضادات الحيوية على  متناهية الصغر لفضةاجسيمات مضاد للجراثيم لهذه المضادات الحيوية. على النقيض لوحظ تأثير 
جسيمات وأخيرا، يمكن أن نخلص إلى أن  ، كان يترواح بين عديم التأثير والمتعارض.كالتالى عترات السالمونيلا المسخدمة
هولة من قبل المستخلصات المائية للروزماري وهي منخفضة التكلفة وطريقة صديقة يمكن أن تنتج بس متناهية الصغر لفضةا
إما وحدها أو في خلطها من  كان مشجعا ضد عترات ال الايكولاي متناهية الصغر لفضةاجسيمات للبيئة. وأيضا أن استخدام 
جيال جديدة من المركبات القاتلة للبكتريا حيث من الممكن  ان تكون مناسبة فى تكوين ا المضادات الحيوية التي تم اختبارها
 .وأمكان استخدامها فى مزارع الدواجن لمنع وعلاج عدوى الايكولاى
 
